Browse all practice questions for the PEBC Cardiology Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

PEBC Cardiology Practice Test course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • Which factor is included in CHA2DS2VASc but not in CHADS2?
  • Which drug class is listed as required in HFrEF?
  • Which of the following is an example of a post-ACS drug class that reduces mortality risk?
  • Which heart failure phenotype is more sensitive to diuretics?
  • New York Heart Association (NYHA) Class I is characterized by?
  • Which clinical finding indicates venous congestion in heart failure?
  • Which is part of the standard ACS treatment regimen?
  • Which of the following is NOT among the four statin-indicated conditions?
  • Which factor adds 2 points in the CHA2DS2VASc score?
  • Which symptom is part of the clinical presentation of atrial fibrillation?
  • Which diet is listed as good for dyslipidemia alongside Mediterranean and Portfolio?
  • Which clotting factors are most relevant in venous thromboembolism?
  • What is the preferred analgesia in an acute myocardial infarction?
  • Ventricular fibrillation is characterized by what?
  • After an acute coronary syndrome, what is the general recommended duration for beta-blocker therapy?
  • What is the target heart rate for those on rate control with atrial fibrillation?
  • What is considered a normal resting heart rate?
  • Which drug is commonly used to reduce cardiovascular risk in PAD?
  • Paroxysmal atrial fibrillation is defined as AF episodes lasting less than how many days?
  • In the CHADS-65 algorithm, if there are no CHADS risk factors and no CAD or PAD, what is recommended?
  • Which antihypertensive is NOT listed as recommended for hypertension in breastfeeding mothers?
  • Which therapy is used to prevent stent thrombosis after MI?
  • Which statement represents a restriction on first-line hypertension therapy?
  • Which lipid parameter is typically calculated rather than directly measured?
  • Which non-pharmacologic measure is recommended for patients with warning signs of vasovagal syncope?
  • Which of the following is NOT listed as a medication that can exacerbate hypertension?
  • At what age should patients without underlying conditions be screened for dyslipidemia?
  • Which medication is commonly used to relieve chest pain and reduce myocardial oxygen demand in ACS?
  • Which of the following is NOT a component of the HAS-BLED bleeding risk score?
  • Which of the following best represents Virchow's triad components?
  • Which statement best describes the normal PR interval and the event it represents?
  • What should initial hypertension treatment be for patients with diabetes?
  • What does the FAST acronym stand for in acute stroke recognition?
  • Cholesterol is produced mainly in which organ, and what factor influences its transport?
  • Which intervention is included in the ACS management plan according to the provided material?
  • After an ACS, what is the recommended duration for ACE inhibitors or ARBs?
  • Which tests are commonly used to diagnose deep vein thrombosis?
  • Which agents are used to prevent arrhythmias after myocardial infarction?
  • Which statement best describes the difference between stable and unstable angina?
  • Which symptom refers to shortness of breath when lying flat?
  • Which statement about PAD symptoms is true?
  • Which symptom would prompt monitoring for statin-associated myopathy?
  • Rupture of artery plaques most commonly leads to which cardiovascular event?
  • Which description matches first-degree AV block?
  • Which statement distinguishes stroke from TIA based on imaging evidence?
  • In primary prevention, which statement describes the benefits and risks of aspirin?
  • Which of the following is a component of the CHADS2 score?
  • Which is an efficacy endpoint for statins?
  • Which of the following is NOT a recognized class of causes of syncope?
  • What is paroxysmal atrial fibrillation?
  • In stable angina management, which nitrate form is used as needed for relief?
  • What is proarrhythmia?
  • Which beta-blocker is NOT among the beta-1 selective agents listed as preferred for regular hypertension?
  • What is the maximum recommended time from first medical contact to thrombolytic therapy in acute coronary syndrome?
  • What should initial hypertension treatment be for patients with stable angina?
  • Which single blood pressure reading constitutes an automatic diagnosis of hypertension?
  • In heart failure management, an additional diuretic is typically given when a patient has gained more than how many kilograms over their dry weight for more than 24 hours?
  • Which beta-blocker is listed as a beta-1 selective agent among the preferred options for regular hypertension?
  • What atrial rate is considered atrial fibrillation?
  • Which antihypertensive class is contraindicated in pregnancy?
  • What is the recommended initial therapy for a patient with a recent myocardial infarction?
  • Which of the following is included as a component of HAS-BLED scoring?
  • Which drug classes are known to increase triglyceride levels?
  • For STEMI patients undergoing PCI, which anticoagulant is generally preferred?
  • For hypertensive patients with a history of stroke or TIA, which initial therapy is recommended?
  • Aspirin post-ACS should be continued indefinitely unless there is a very high risk of bleeding. Which option correctly reflects this guidance?
  • What therapy is commonly used for secondary prevention in non-cardioembolic (atherosclerotic) stroke?
  • Which statement is NOT a feature of stable angina?
  • Which of the following is a risk factor for atrial fibrillation?
  • NYHA Class IV is defined by?
  • For a patient with an LVEF <30% after ACS, beta-blocker therapy should be continued for how long?
  • Which statement best describes the CHADS2 scoring system?
  • In NSTEMI management, the preferred anticoagulant is?
  • Which statement accurately describes CK and troponin elevations in myocardial infarction?
  • If ACE inhibitors are not tolerated in chronic kidney disease, which alternative is used?
  • ST-elevation myocardial infarction (STEMI) is best characterized by which occlusion status?
  • What should initial hypertension treatment be for patients with chronic kidney disease?
  • Which test is commonly used in diagnosing DVT in addition to ultrasound?
  • What is the normal PR interval on an ECG?
  • Orthostatic hypotension is defined as?
  • Lipoprotein(a) is best described as which of the following?
  • Which antihypertensive is NOT listed as recommended during pregnancy?
  • In the CHADS-65 algorithm, which condition automatically indicates initiation of oral anticoagulation?
  • Besides ACE inhibitors, which agent can be used to prevent ventricular remodeling after MI?
  • What is the LDL-C target for ASCVD?
  • Which statement about antithrombotic therapy in symptomatic PAD is correct for patients without a history of ACS?
  • LDL-C target for familial hypercholesterolemia?
  • Which systems are activated during acute heart failure compensation?
  • If triglycerides are elevated, which add-on is not preferred?
  • Which form of calcium channel blocker is considered first-line in hypertension management?
  • What is the dose of rivaroxaban used in PAD?
  • Which of the following is NOT a compensatory mechanism activated in acute heart failure?
  • LDL-C target for primary prevention?
  • Which statement best distinguishes major cardiovascular risk factors from minor risk factors?
  • Why is Non-HDL-C calculated in lipid assessment?
  • What is the potentially fatal consequence of atrial fibrillation?
  • What is the #1 action patients can take to improve PAD?
  • Which symptom is commonly associated with heart failure?
  • Which test is used specifically as a biomarker for acute heart failure?
  • Immediate management for ventricular fibrillation should include?
  • Aspirin in primary prevention is associated with increased risk of which cancer type?
  • Which therapy is unique to cardioembolic stroke prevention compared to atherosclerotic stroke prevention?
  • What are the two main classifications of stroke?
  • NYHA Class II is best described as?
  • For P2Y12 inhibitors after ACS, what is the general duration?
  • Which of the following is a risk factor for atrial fibrillation?
  • Which of the following is a risk factor for atrial fibrillation?
  • Which statement best describes the use of fludrocortisone and midodrine in vasovagal syncope?
  • Which component is related to sex in the CHA2DS2VASc scoring system?
  • Which test is used to diagnose PAD?
  • What is secondary hypertension and its most common cause?
  • What should initial hypertension treatment be for patients with coronary artery disease?
  • Which symptom is commonly associated with atrial fibrillation?
  • Which statement correctly describes how LDL-C is estimated in a standard lipid panel?
  • What is the CHADS score used to estimate?
  • What is the normal QRS duration on an ECG?
  • Non-HDL-C is particularly useful as a risk marker in which scenario?
  • Which presentation most suggests a pulmonary embolism?
  • LDL target for ASCVD equals which value?
  • LDL-C target is typically assessed after what timeframe after starting a statin?
  • Fibrinolytics such as tenecteplase or alteplase are appropriate in which scenario?
  • NYHA Class III is described as?
  • Which blood pressure value defines an automatic ER visit criterion when the patient is asymptomatic?
  • ApoB has what clinical significance in lipid panels?
  • Which group is considered for aspirin therapy in primary prevention?
  • When is rhythm control preferred in AF patients?
  • Which description matches third-degree AV block?
  • Which statement best describes a feature of stable angina?
  • A large difference in systolic blood pressure between the legs on evaluation suggests PAD.
  • Which measurement most directly reflects the number of atherogenic lipoprotein particles?
  • Cardiovascular events endpoint in statin trials is typically assessed after about what period?
  • When newly diagnosed with AF, what therapies should be assessed?
  • For secondary prevention after cardioembolic stroke, which combination is appropriate?
  • What is the ideal door-to-needle time for thrombolysis in acute coronary syndrome?
  • Which of the following is a risk factor for atrial fibrillation?
  • Which is a safety endpoint for statins?
  • Which of the following is a sign of heart failure that a clinician might observe on examination?
  • Which finding is a sign of fluid overload in heart failure?
  • Which factor is a major risk factor for venous thromboembolism?
  • Which diet is recommended for dyslipidemia?
  • What are the normal and reduced ejection fraction ranges?
  • Which symptom cluster is a red flag for venous thromboembolism?
  • What does valvular atrial fibrillation mean?
  • Which of the following is commonly listed as a symptom of heart failure?
  • Typical add-on to statins in dyslipidemia?
  • Which drug classes are known to increase LDL-C levels?
  • What best defines vasovagal syncope?
  • Which drug class is associated with age-based restrictions in first-line therapy (for younger patients)?
  • Which pair of physiological changes are cited as causes of hypertension?
  • Which statement best describes Virchow's triad components?
  • For beta-blocker therapy after MI with a single affected artery, duration is generally:
  • Which antithrombotic regimen is used after PAD revascularization?
  • Which statement best describes a limitation of the Framingham risk score?
  • In stable angina, which statement correctly describes the line of therapy?
  • In patients with high risk of recurrent events after ACS, the duration of P2Y12 inhibitor therapy should be:
  • What is the normal QTc interval on an ECG?
  • Which statement correctly describes the relationship between unstable angina, NSTEMI, and STEMI in terms of occlusion and biomarkers?
  • Which statement correctly describes HF-pEF versus HF-rEF?
  • Which factor is a major reason for selecting third-line therapy in stable angina management?
  • Which agent is used to prevent ventricular rupture post MI?
  • Which category describes rupture of a blood vessel leading to bleeding in the brain?
  • Which of the following is NOT a listed risk factor for atrial fibrillation in the source material?
  • Which statement best describes HF-pEF in relation to ejection fraction?
  • Which of the following is one of the five first-line drug classes for treating hypertension?
  • What is the LDL-C target for Diabetes and CKD?
  • How is asymptomatic PAD managed?
  • Which of the following is NOT a component of the HAS-BLED bleeding risk score?
  • Which components are measured in a standard cholesterol panel?
  • Which BP component has a larger impact on overall mortality in hypertension?
  • Which of the following is an antiplatelet agent used in ACS treatment?
  • Which agent is used to prevent ventricular remodeling post MI?
  • If PAD symptoms are unilateral, what testing step is recommended?
  • Which description matches second-degree AV block?
  • Which agent is used to prevent recurrent myocardial infarctions?
  • What is considered the strongest single risk factor for venous thromboembolism?
  • The QRS complex predominantly represents which event in the cardiac cycle?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy